Macular Degeneration

Showing NaN - NaN of 22

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Macular Degeneration Trial in United Kingdom, United States (BI 754132)

Terminated
  • Macular Degeneration
  • BI 754132
  • Beverly Hills, California
  • +12 more
Aug 23, 2022

Macular Degeneration, Geographic Atrophy Trial in Worldwide (IONIS-FB-LRx, Placebo)

Recruiting
  • Macular Degeneration
  • Geographic Atrophy
  • Phoenix, Arizona
  • +83 more
Aug 19, 2022

Dry Age-related Macular Degeneration, Geographic Atrophy, Macular Degeneration Trial in United States (GEM103)

Terminated
  • Dry Age-related Macular Degeneration
  • +4 more
  • Phoenix, Arizona
  • +28 more
Mar 22, 2022

Neovascular Age-related Macular Degeneration, Retinal Disease, Retinal Degeneration Trial in United States (GEM103, sham + SoC)

Completed
  • Neovascular Age-related Macular Degeneration
  • +3 more
  • GEM103
  • sham + SoC
  • Phoenix, Arizona
  • +22 more
Mar 22, 2022

Geographic Atrophy, Macular Degeneration Trial in Worldwide (Zimura, Sham)

Completed
  • Geographic Atrophy
  • Macular Degeneration
  • Phoenix, Arizona
  • +77 more
Mar 17, 2022

Macular Degeneration Trial in Worldwide (Ranibizumab)

Completed
  • Macular Degeneration
  • Ranibizumab
  • Gilbert, Arizona
  • +101 more
Mar 11, 2022

Geographic Atrophy, Macular Degeneration Trial in Worldwide (Zimura, Sham)

Active, not recruiting
  • Geographic Atrophy
  • Macular Degeneration
  • Beverly Hills, California
  • +208 more
Sep 14, 2021

Macular Degeneration Trial in United States (Abicipar pegol)

Completed
  • Macular Degeneration
  • Abicipar pegol
  • Phoenix, Arizona
  • +36 more
Jul 17, 2020

Macular Degeneration Trial in Worldwide (Abicipar Pegol, Ranibizumab, Sham Procedure)

Completed
  • Macular Degeneration
  • Abicipar Pegol
  • +2 more
  • Birmingham, Alabama
  • +186 more
Jul 17, 2020

Geographic Atrophy, Macular Degeneration Trial in Worldwide (400 µg Brimonidine Implant, Sham)

Terminated
  • Geographic Atrophy
  • Macular Degeneration
  • 400 µg Brimonidine Implant
  • Sham
  • Phoenix, Arizona
  • +40 more
Mar 29, 2019

Macular Degeneration Trial in United States (Abicipar pegol)

Completed
  • Macular Degeneration
  • Abicipar pegol
  • Gilbert, Arizona
  • +17 more
Feb 6, 2018

Macular Degeneration Trial in Worldwide (pazopanib eye drops, , ranibizumab intravitreal injection)

Completed
  • Macular Degeneration
  • pazopanib eye drops
  • +2 more
  • Peoria, Arizona
  • +76 more
Dec 7, 2017

Macular Degeneration Trial in Australia, Italy, United States (Pazopanib)

Completed
  • Macular Degeneration
  • Beverly Hills, California
  • +16 more
Oct 31, 2017

Macular Degeneration Trial in Worldwide (Pazopanib)

Completed
  • Macular Degeneration
  • Tucson, Arizona
  • +26 more
Oct 18, 2017

Macular Degeneration Trial in United States (Pazopanib)

Completed
  • Macular Degeneration
  • Beverly Hills, California
  • +6 more
Nov 7, 2017

Macular Degeneration Trial in France, Germany, United States (pazopanib eye drops)

Terminated
  • Macular Degeneration
  • pazopanib eye drops
  • Phoenix, Arizona
  • +14 more
Aug 23, 2017

Macular Degeneration Trial in Worldwide (Regorafenib, ophthalmic oily suspension (BAY73-4506), Sham IVT, Ranibizumab)

Terminated
  • Macular Degeneration
  • Regorafenib, ophthalmic oily suspension (BAY73-4506)
  • +3 more
  • Tucson, Arizona
  • +148 more
Jul 25, 2016

Macular Degeneration Trial in United States (VEGF Trap Eye)

Completed
  • Macular Degeneration
  • VEGF Trap Eye
  • Peoria, Arizona
  • +32 more
Jun 10, 2013

Macular Degeneration Trial in Canada, United States (ranibizumab, aflibercept injection (VEGF Trap-Eye, BAY86-5321))

Completed
  • Macular Degeneration
  • ranibizumab
  • aflibercept injection (VEGF Trap-Eye, BAY86-5321)
  • Birmingham, Alabama
  • +187 more
Dec 20, 2012

Macular Degeneration, Choroidal Neovascularization Trial in United States (TG100801)

Terminated
  • Macular Degeneration
  • Choroidal Neovascularization
  • Tucson, Arizona
  • +7 more
Mar 25, 2010